China Regenerative Medicine International Limited (HKG:8158)

HKG:8158 Revenue

China Regenerative Medicine International had revenue of 27.39M HKD in the half year ending June 30, 2025, a decrease of -63.09%. This brings the company's revenue in the last twelve months to 58.22M, up 5.75% year-over-year. In the year 2024, China Regenerative Medicine International had annual revenue of 90.62M with 30.41% growth.

• Revenue (ttm): 58.22M
• Revenue Growth: +5.75%
• P/S Ratio: 1.88
• Revenue / Employee: 2.43M
• Employees: 24
• Market Cap: 109.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	90.62M	21.13M	30.41%
Dec 31, 2023	69.49M	27.95M	67.29%
Dec 31, 2022	41.54M	-241.36M	-85.32%
Dec 31, 2021	282.90M	100.76M	55.32%
Dec 31, 2020	182.14M	162.77M	840.54%